Logo
Unionpedia
Communication
Get it on Google Play
New! Download Unionpedia on your Android™ device!
Free
Faster access than browser!
 

Monoclonal antibody and Panitumumab

Shortcuts: Differences, Similarities, Jaccard Similarity Coefficient, References.

Difference between Monoclonal antibody and Panitumumab

Monoclonal antibody vs. Panitumumab

Monoclonal antibodies (mAb or moAb) are antibodies that are made by identical immune cells that are all clones of a unique parent cell. Panitumumab (INN), formerly ABX-EGF, is a fully human monoclonal antibody specific to the epidermal growth factor receptor (also known as EGF receptor, EGFR, ErbB-1 and HER1 in humans).

Similarities between Monoclonal antibody and Panitumumab

Monoclonal antibody and Panitumumab have 7 things in common (in Unionpedia): Amgen, Antibody-dependent cell-mediated cytotoxicity, Cetuximab, Colorectal cancer, Epidermal growth factor receptor, Food and Drug Administration, Pharmacokinetics.

Amgen

Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California.

Amgen and Monoclonal antibody · Amgen and Panitumumab · See more »

Antibody-dependent cell-mediated cytotoxicity

The antibody-dependent cell-mediated cytotoxicity (ADCC), also referred to as antibody-dependent cellular cytotoxicity, is a mechanism of cell-mediated immune defense whereby an effector cell of the immune system actively lyses a target cell, whose membrane-surface antigens have been bound by specific antibodies.

Antibody-dependent cell-mediated cytotoxicity and Monoclonal antibody · Antibody-dependent cell-mediated cytotoxicity and Panitumumab · See more »

Cetuximab

Cetuximab is an epidermal growth factor receptor (EGFR) inhibitor used for the treatment of metastatic colorectal cancer, metastatic non-small cell lung cancer and head and neck cancer.

Cetuximab and Monoclonal antibody · Cetuximab and Panitumumab · See more »

Colorectal cancer

Colorectal cancer (CRC), also known as bowel cancer and colon cancer, is the development of cancer from the colon or rectum (parts of the large intestine).

Colorectal cancer and Monoclonal antibody · Colorectal cancer and Panitumumab · See more »

Epidermal growth factor receptor

The epidermal growth factor receptor (EGFR; ErbB-1; HER1 in humans) is a transmembrane protein that is a receptor for members of the epidermal growth factor family (EGF family) of extracellular protein ligands.

Epidermal growth factor receptor and Monoclonal antibody · Epidermal growth factor receptor and Panitumumab · See more »

Food and Drug Administration

The Food and Drug Administration (FDA or USFDA) is a federal agency of the United States Department of Health and Human Services, one of the United States federal executive departments.

Food and Drug Administration and Monoclonal antibody · Food and Drug Administration and Panitumumab · See more »

Pharmacokinetics

Pharmacokinetics (from Ancient Greek pharmakon "drug" and kinetikos "moving, putting in motion"; see chemical kinetics), sometimes abbreviated as PK, is a branch of pharmacology dedicated to determining the fate of substances administered to a living organism.

Monoclonal antibody and Pharmacokinetics · Panitumumab and Pharmacokinetics · See more »

The list above answers the following questions

Monoclonal antibody and Panitumumab Comparison

Monoclonal antibody has 177 relations, while Panitumumab has 22. As they have in common 7, the Jaccard index is 3.52% = 7 / (177 + 22).

References

This article shows the relationship between Monoclonal antibody and Panitumumab. To access each article from which the information was extracted, please visit:

Hey! We are on Facebook now! »